Engagement of p75/AIRM1 or CD33 inhibits the proliferation of normal or leukemic myeloid cells

被引:124
作者
Vitale, C
Romagnani, C
Falco, M
Ponte, M
Vitale, M
Moretta, A
Bacigalupo, A
Moretta, L
Mingari, MC
机构
[1] Ist Nazl Ric Canc, I-16132 Genoa, Italy
[2] Univ Genoa, Dipartimento Med Sperimentale, I-16132 Genoa, Italy
[3] Univ Genoa, Dipartimento Oncol Biol & Genet, I-16132 Genoa, Italy
[4] Osped San Martino Genova, Ctr Trapianti Midollo Osseo, Div Ematol, I-16132 Genoa, Italy
关键词
D O I
10.1073/pnas.96.26.15091
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
P75/AIRM1 is a recently identified surface molecule that belongs to the sialoadhesin family and displays homology with the myeloid cell antigen CD33, In lymphoid cells, p75/AIRM1 is confined to natural killer cells and mediates inhibition of their cytolytic activity. In this study, we show that p75/AIRM1 is also expressed by cells of the myelomonocytic cell lineage, in which it appears at a later stage as compared with CD33, In vitro proliferation and differentiation of cord blood-derived CD34(+) cells (induced by stem cell factor and granulocyte-macrophage colony-stimulating factor) were consistently inhibited by the addition of anti-p75/AIRM1 mAb, Engagement of CD33 led to inhibition in some experiments. A sharp decrease of cell proliferation/survival was detected in all three p75/AIRM1+ chronic myeloid leukemias analyzed when cultured in the presence of either anti-p75/AIRM1 or anti-CD33 mAbs, Thus, the present study suggests that p75/AIRM1 and CD33 may play a regulatory role in normal myelopoiesis and may be viewed as suitable target molecules to counteract the proliferation/survival of chronic myeloid leukemias.
引用
收藏
页码:15091 / 15096
页数:6
相关论文
共 19 条
[1]   PRECURSORS OF COLONY-FORMING CELLS IN HUMANS CAN BE DISTINGUISHED FROM COLONY-FORMING CELLS BY EXPRESSION OF THE CD33 AND CD34 ANTIGENS AND LIGHT SCATTER PROPERTIES [J].
ANDREWS, RG ;
SINGER, JW ;
BERNSTEIN, ID .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 169 (05) :1721-1731
[2]  
CANTONI C, 2000, IN PRESS EUR J IMMUN
[3]  
CARON PC, 1995, CLIN CANCER RES, V1, P63
[4]  
CARON PC, 1994, CANCER, V73, P1049, DOI 10.1002/1097-0142(19940201)73:3+<1049::AID-CNCR2820731344>3.0.CO
[5]  
2-1
[6]  
Caron PC, 1998, CLIN CANCER RES, V4, P1421
[7]  
DEXTER TM, 1987, ANNU REV CELL BIOL, V3, P423
[8]   Identification and molecular cloning of p75/AIRM1, a novel member of the sialoadhesin family that functions as an inhibitory receptor in human natural killer cells [J].
Falco, M ;
Biassoni, R ;
Bottino, C ;
Vitale, M ;
Sivori, S ;
Augugliaro, R ;
Moretta, L ;
Moretta, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (06) :793-801
[9]   CHARACTERIZATION OF CD33 AS A NEW MEMBER OF THE SIALOADHESIN FAMILY OF CELLULAR INTERACTION MOLECULES [J].
FREEMAN, SD ;
KELM, S ;
BARBER, EK ;
CROCKER, PR .
BLOOD, 1995, 85 (08) :2005-2012
[10]   CD22 associates with protein tyrosine phosphatase 1C, Syk, and phospholipase C-gamma 1 upon B cell activation [J].
Law, CL ;
Sidorenko, SP ;
Chandran, KA ;
Zhao, ZH ;
Shen, SH ;
Fischer, EH ;
Clark, EA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (02) :547-560